Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis

Published:2021-06-26 Issue:2 Volume:71 Page:373-386
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Lazarus Gilbert^ORCID,Budiman Refael Alfa,Rinaldi Ikhwan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-021-02990-9.pdf

Reference54 articles.

1. World Health Organization (2020) Coronavirus disease (COVID-19): weekly epidemiological update, 14 September 2020. World Health Organization. https://apps.who.int/iris/handle/10665/334304. Accessed 15 Sept 2020

2. Ofori-Asenso R, Ogundipe O, Agyeman AA et al (2020) Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis. Ecancermedicalscience 14:1047. https://doi.org/10.3332/ecancer.2020.1047

3. Giannakoulis VG, Papoutsi E, Siempos II (2020) Effect of cancer on clinical outcomes of patients With COVID-19: a meta-Analysis of patient data. JCO Glob Oncol 6:799–808. https://doi.org/10.1200/GO.20.00225

4. ElGohary GM, Hashmi S, Styczynski J et al (2020) The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther S1658–3876(20):30122–30129. https://doi.org/10.1016/j.hemonc.2020.07.005

5. Lazarus G, Audrey J, Iskandar AWB (2019) Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: a comprehensive systematic review. Oncol Rev. https://doi.org/10.4081/oncol.2019.425

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19;Current Oncology;2024-09-10

2. Association of immune checkpoint inhibitors with SARS-CoV-2 infection rate and prognosis in patients with solid tumors: a systematic review and meta-analysis;Frontiers in Immunology;2024-06-03

3. Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era;The Lancet Regional Health - Europe;2023-08

4. SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors;Cell Death & Disease;2023-06-30

5. A Case of Small Cell Lung Cancer with COVID-19 Pneumonia During Chemoimmunotherapy;Haigan;2023-02-20